| 000 | 01910 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514230250.0 | ||
| 264 | 0 | _c20050901 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1397-3142 | ||
| 024 | 7 |
_a10.1111/j.1399-3046.2005.00296.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenfield, Mark R | |
| 245 | 0 | 0 |
_aA randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. _h[electronic resource] |
| 260 |
_bPediatric transplantation _cJun 2005 |
||
| 300 |
_a282-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 |
_aGraft Survival _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xtherapeutic use |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aTejani, Amir | |
| 700 | 1 | _aHarmon, William E | |
| 700 | 1 | _aMcDonald, Ruth | |
| 700 | 1 | _aStablein, Donald M | |
| 700 | 1 | _aMcIntosh, Matthew | |
| 700 | 1 | _aRose, Stephen | |
| 773 | 0 |
_tPediatric transplantation _gvol. 9 _gno. 3 _gp. 282-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-3046.2005.00296.x _zAvailable from publisher's website |
| 999 |
_c15572202 _d15572202 |
||